Tempus AI

Tempus AI

AI for healthcare

Company website
Capitalization

$$5943.6mil

Foundation year

2015

About

The focus is on the use of AI (artificial intelligence) in healthcare. This led to the creation of the Tempus Platform, which includes proprietary software and data pipelines. As a result of this proprietary technology, the company has accumulated what is considered to be one of the largest libraries of clinical and molecular oncology data in the world.

Underwriters

Morgan Stanley, J.P. Morgan, Allen & Company, BofA Securities, TD Cowen, Stifel, William Blair


2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.